• Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Analysis in Bladder Cancer
  • Tissue Transglutaminase (tTG) Antibody, IgA
  • Alkaline Phosphatase (ALP), Serum
  • Phenosense Combination HIV Drug Resistance Assay
  • Allergen Specific IgE, Respiratory (Environmental Inhalant) Profile
  • Heroin, Urine
  • Arsenic Fractionation, 24 Hour, Urine
  • Cytochrome P450 2D6 (CYP2D6) Genotyping
  • Polyoma BK Virus, PCR, Quantitative, Urine
  • Immunoglobulin Gene Rearrangement (B-Cell Clonality), Bone Marrow
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
Medical Test

Interpretation
Access to MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue is restricted.